DK0706377T3 - Excipiens med forlænget frigivelse - Google Patents

Excipiens med forlænget frigivelse

Info

Publication number
DK0706377T3
DK0706377T3 DK95914917T DK95914917T DK0706377T3 DK 0706377 T3 DK0706377 T3 DK 0706377T3 DK 95914917 T DK95914917 T DK 95914917T DK 95914917 T DK95914917 T DK 95914917T DK 0706377 T3 DK0706377 T3 DK 0706377T3
Authority
DK
Denmark
Prior art keywords
release excipient
extended release
cross
heteropolysaccharide
linking
Prior art date
Application number
DK95914917T
Other languages
Danish (da)
English (en)
Inventor
Anand R Baichwal
Troy W Mccall
Original Assignee
Mendell Co Inc Edward
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mendell Co Inc Edward filed Critical Mendell Co Inc Edward
Application granted granted Critical
Publication of DK0706377T3 publication Critical patent/DK0706377T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Character Spaces And Line Spaces In Printers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Superstructure Of Vehicle (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Push-Button Switches (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
DK95914917T 1994-04-25 1995-03-21 Excipiens med forlænget frigivelse DK0706377T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23262594A 1994-04-25 1994-04-25
PCT/US1995/003825 WO1995028916A1 (en) 1994-04-25 1995-03-21 Sustained release excipient

Publications (1)

Publication Number Publication Date
DK0706377T3 true DK0706377T3 (da) 2002-04-02

Family

ID=22873888

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95914917T DK0706377T3 (da) 1994-04-25 1995-03-21 Excipiens med forlænget frigivelse

Country Status (18)

Country Link
EP (2) EP0706377B1 (zh)
JP (1) JP3279318B2 (zh)
KR (1) KR100232020B1 (zh)
CN (1) CN1131023C (zh)
AT (2) ATE308318T1 (zh)
AU (1) AU705378B2 (zh)
CA (1) CA2164513C (zh)
DE (2) DE69524358T2 (zh)
DK (1) DK0706377T3 (zh)
ES (2) ES2164764T3 (zh)
FI (1) FI119353B (zh)
HK (1) HK1040487B (zh)
HU (1) HU219818B (zh)
IL (1) IL113167A (zh)
MX (1) MX9600022A (zh)
PT (1) PT706377E (zh)
TW (1) TW357085B (zh)
WO (1) WO1995028916A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
WO1998044951A2 (en) * 1997-04-04 1998-10-15 Monsanto Company Hydrolysable delivery system using cross-linked polymeric resins as vehicles
AU6783498A (en) 1997-04-04 1998-10-30 Monsanto Company Ph-selective delivery system using cross-linked polymeric resins as vehicles
CA2452872A1 (en) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
AU2002337686B2 (en) * 2001-09-26 2008-05-15 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
EP1499295A4 (en) * 2002-04-05 2006-04-05 Penwest Pharmaceuticals Co EXTENDED RELEASE METOPROLOL FORMULATIONS
KR101999055B1 (ko) * 2018-02-28 2019-10-01 경북대학교 산학협력단 과황산 이온 서방성 구조체, 이의 제조방법 및 이를 이용한 유기 오염 물질 처리 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303691A (en) * 1977-11-09 1981-12-01 Anderson, Clayton & Co. Proteinaceous food product
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form

Also Published As

Publication number Publication date
DE69524358T2 (de) 2002-06-13
IL113167A (en) 2001-01-28
DE69524358D1 (de) 2002-01-17
WO1995028916A1 (en) 1995-11-02
MX9600022A (es) 1998-06-30
EP0706377B1 (en) 2001-12-05
FI956209A0 (fi) 1995-12-22
AU2198295A (en) 1995-11-16
HUT73636A (en) 1996-08-28
EP1145712A1 (en) 2001-10-17
TW357085B (en) 1999-05-01
EP0706377A4 (en) 1996-11-06
EP1145712B1 (en) 2005-11-02
IL113167A0 (en) 1995-06-29
HK1040487B (zh) 2006-05-12
HK1040487A1 (en) 2002-06-14
PT706377E (pt) 2002-05-31
AU705378B2 (en) 1999-05-20
CA2164513A1 (en) 1995-11-02
CN1131023C (zh) 2003-12-17
FI119353B (fi) 2008-10-31
HU9503456D0 (en) 1996-02-28
DE69534575D1 (de) 2005-12-08
JPH08512061A (ja) 1996-12-17
HU219818B (hu) 2001-08-28
DE69534575T2 (de) 2006-07-13
JP3279318B2 (ja) 2002-04-30
FI956209A (fi) 1995-12-22
ES2164764T3 (es) 2002-03-01
ATE209906T1 (de) 2001-12-15
ES2246961T3 (es) 2006-03-01
KR100232020B1 (ko) 1999-12-01
EP0706377A1 (en) 1996-04-17
CA2164513C (en) 1999-09-21
ATE308318T1 (de) 2005-11-15
KR960703016A (ko) 1996-06-19
CN1127469A (zh) 1996-07-24

Similar Documents

Publication Publication Date Title
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
FI961996A0 (fi) Pitkitetysti vapauttavat valmisteet metoprololin 24 tunnin pituiseksi vapauttamiseksi
DE69523438T2 (de) Orale metoprolol-dosisform des typs "einmal täglich"
SG28285A1 (en) Method for molding dental restorations and related apparatus
ATE2667T1 (de) Antidepressiv wirkende derivate des trans-4phenyl-1,2,3,4-tetrahydro-1-naphthalin-amins und pharmazeutische zusammensetzungen daraus.
DK0706377T3 (da) Excipiens med forlænget frigivelse
EP0461586A3 (en) Dental composition for impression-taking
IL111580A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
EP0380989A3 (en) Plaster for transdermal administration
HK1004549A1 (en) Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent central nervous system stimulant or sigma receptor agonist
ZA916570B (en) Desensitizing dental composition
ATA259590A (de) 3-(n-methyl-n-alkyl)-amino-2-methoxymethylenpro an-1-ol-derivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE2961713D1 (en) Organic diamine compounds for use as oral hypoglycemic agents and pharmaceutical compositions thereof
ATA252892A (de) Benzofuranylimidazolderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
FR2687068B1 (fr) Composition pour empreintes dentaires.
ITMI940515V0 (it) Dispositivo simmetropredeterminatore per la riproduzione del tracciato dell'arcata dentale
ITMI911450A1 (it) Endoapparecchio per il ripristino dell'articolazione coxofemorale
IT1235158B (it) Composizione farmaceutica a base di derivati carbazolici e metanolici nonche' impiego e confezione per essa